The UK Biobank has now scanned 100,000 people, taking recordings of hearts, brains, blood vessels and bones. As the world's ...

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

Conditions like dementia, migraines and epilepsy are all too common, but many neurological patients in Scotland struggle to ...

The global digital biomarkers market size was valued at USD 4.15 billion in 2024 and is predicted to hit around USD 32.37 ...